Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending January 16, 2008. The report serves as a notification of transactions involving directors or persons discharging managerial responsibility, specifically regarding the Deferred Investment Award Plan.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification of a specific share transaction rather than a financial performance report.
Material Changes
The only material change disclosed is an increase in the shareholding of Mr. E J Gray. This increase resulted from the re-investment of a dividend paid to shareholders on January 10, 2008, at a price of GBP 13.88 per share.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly details a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
Key Facts for Investor Verification
- Transaction Date: January 16, 2008.
- Individual Involved: Mr. E J Gray.
- Transaction Type: Increase in Ordinary Shares via dividend re-investment.
- Share Price: GBP 13.88 per share.
- Dividend Payment Date: January 10, 2008.